Patents by Inventor Tang-bo Chung WU

Tang-bo Chung WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190060365
    Abstract: Disclosed is a pharmaceutical composition for treating chronic obstructive pulmonary disease, comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method for treating chronic obstructive pulmonary disease in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent.
    Type: Application
    Filed: August 25, 2017
    Publication date: February 28, 2019
    Applicant: Meridigen Biotech Co., Ltd.
    Inventors: Chang-Yo HSUAN, Willie LIN, Yu-Chin SU, Tang-bo Chung WU, Yu-Chieh Wen
  • Publication number: 20190054144
    Abstract: Disclosed is a pharmaceutical composition for treating ischemic stroke, comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method for treating ischemic stroke in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of human mesenchymal stem cells, human serum albumin, and a pharmaceutically acceptable carrier or diluent. In addition, a method for promoting secretion of hepatocyte growth factor by human mesenchymal stem cells is disclosed.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 21, 2019
    Applicant: Meridigen Biotech Co., Ltd.
    Inventors: Chang-Yo HSUAN, Willie LIN, Yu-Chin SU, Tang-bo Chung WU